APBI calls for greater participant diversity in industry studies
15 June 2025. Related: Early access, Special reports, Research studies.
Research studies
TAG challenges HIV vaccine cuts as Robert F. Kennedy fires entire CDC vaccine expert advisory panel
6 June 2025. Related: Early access, Treatment access, Activism & advocacy, Research studies.
Scientific, legal and ethical crisis from halting ongoing NIH studies: TAG statement
22 May 2025. Related: Treatment access, Activism & advocacy, Research studies.
Trump bans travel for US government scientists, presentations restricted, language bans, documents disappearing
23 January 2025. Related: Treatment access, Activism & advocacy, Research studies.
UK HIV Positive Voices survey: many people doing well but life is still difficult for others; growing belief in U=U
9 February 2024. Related: Special reports, Ageing and life expectancy, Activism & advocacy, Research studies, Other news.
Uganda hate law blocks HIV research: join 300 leading researchers in sign-on protest
4 January 2024. Related: Special reports, Treatment access, Activism & advocacy, Research studies.
EACS 2023: Prevalence of doravirine drug resistance in large cohort in British Columbia
1 December 2023. Related: Conference reports, Research studies.
Switch study for people with insomnia using dolutegravir: still enrolling
3 October 2022. Related: Research studies.
START study: call for participants to attend final visit – please help…
17 September 2021. Related: Research studies.
IAS 2021: Proving efficacy of next generation PrEP: counterfactual controls in lenacapavir and islatravir studies
1 August 2021. Related: Conference reports, HIV prevention and transmission, Research studies.
Switch study for people with insomnia using dolutegravir
22 March 2021. Related: Research studies.
UK study for people with triple-class drug resistance
24 February 2021. Related: Drug resistance, Research studies.
US requires informed consent forms for clinical studies to be posted online
12 March 2019. Related: Research studies, Other news.
How to evaluate PrEP and vaccines: urgency for next generation compounds
13 November 2018. Related: Conference reports, HIV prevention and transmission, Cure-related research, Research studies.
ViiV announces phase 3 study switching to dolutegravir/3TC dual therapy from TAF-containing ART
9 February 2018. Related: Antiretrovirals, Research studies.
Updates from the PrEP IMPACT study – November 2017
28 November 2017. Related: HIV prevention and transmission, Research studies.
Exercise associated with significantly reduced risk of serious health problems and higher CD4 counts in large multicentre US study
1 October 2016. Related: Conference reports, Research studies.
Non-AIDS mortality in England and Wales in HIV positive vs general population
1 June 2016. Related: Conference reports, Ageing and life expectancy, Research studies.
Why START would make an excellent long-term cohort
1 December 2015. Related: Research studies.
Why dolutegravir might get us closer to ending AIDS: next step, further research
1 December 2015. Related: Research studies.